Research advances in molecular targeted therapy for pancreatic cancer
10.3969/j.issn.1001-5256.2016.10.048
- VernacularTitle:胰腺癌分子靶向治疗的研究进展
- Author:
Ying XU
1
;
Shulong DAI
Author Information
1. Department of Gastroenterology, Huaian First Hospital Affiliated to Nanjing Medical University, Huaian, Jiangsu 223300, China
- Publication Type:Research Article
- Keywords:
pancreatic neoplasms;
targeted therapy;
review
- From:
Journal of Clinical Hepatology
2016;32(10):2026-2028
- CountryChina
- Language:Chinese
-
Abstract:
Pancreatic cancer remains one of the malignant tumors with the worst prognosis, and its incidence is associated with Western diet, smoking, drinking, obesity, chronic pancreatitis, and a family history of pancreatic cancer. Currently, the treatment of pancreatic cancer focuses on surgery and chemotherapy, but no ideal therapeutic effect has been achieved. An understanding of the specific molecular mechanism of the development of pancreatic cancer helps to better prevent and treat pancreatic cancer. This article introduces the latest advances in the specific molecular mechanism of the development of pancreatic cancer and its targeted therapy and points out that molecular-targeted therapy in addition to traditional treatment helps to improve the prognosis of patients with pancreatic cancer.
